The HLA system
The human leukocyte antigen (HLA) system, also known as the major histocompatibility complex (MHC), is a complex of genes located on chromosome 6 that encode cell-surface proteins responsible for regulating the immune system. The HLA system is central to the body's defense against disease, helping the immune system distinguish self from non-self. Mutations in HLA genes have been linked to autoimmune diseases including type 1 diabetes and celiac disease, and the HLA complex is the principal determinant of organ-transplant compatibility.
The HLA system is divided into two classes: HLA class I (HLA-A, -B, -C) and class II (HLA-DR, -DP, -DQ). HLA glycoproteins are decisive contributors to the defense against foreign antigens and control the immunological identity of an individual. This is the genetic system Paul Ehrlich postulated at the beginning of the 20th century to be responsible for the differentiation between "self" and "non-self" — between tolerance toward one's own tissue and active immune defense against foreign invaders.
HLA-typed cancer cells from Cytion
Cytion aims to provide diverse HLA haplotypes to medical and immunological research organizations, representing an individual's unique HLA complex. This is achieved by collecting B-LCLs and various human tumor cell lines and performing high-resolution NGS HLA typing. Our collection includes a wide range of HLA-typed cancer cells from different organs, used to test potential therapies and detect cross-reactions. With 272 HLA-typed cell lines readily available, you can eliminate the need for in-house cell HLA typing.



